Trial Profile
A retrospective study evaluating effectiveness and safety of Pimavanserin in patients with Parkinson's disease psychosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Dec 2018
Price :
$35
*
At a glance
- Drugs Pimavanserin (Primary)
- Indications Parkinson's disease
- Focus Adverse reactions; Therapeutic Use
- 06 Dec 2018 New trial record